Demographic Factors for All Evaluable Participants and the Subset that was HIV Positive and Tested for Drug Resistance in MTN-009.

<p>Notes: SD = Standard Deviation.</p

CD4+ T Cell Counts and HIV-1 RNA Levels of HIV-1 Positive Participants.

<p>Histogram showing frequency of HIV positive participants (n = 400) that have (A) CD4+ T cell counts <200 cells/mm³ indicating risk for AIDS, 200–349 cells/mm³ indicating treatment eligibility, and >350 cells/mm³; and (B) varying levels of HIV-1 RNA (copies/ml).</p

Consort Diagram.

<p>Consort Diagram.</p

Major Drug Resistance Mutation Profiles Detected.

<p>Major Drug Resistance Mutation Profiles Detected.</p

Frequency of ARV Resistance Mutations.

<p>Histogram showing number of women with drug resistant HIV infection that had each of the following protease inhibitor (PI), nucleoside reverse transcriptase inhibitor (NRTI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations M46L, I85V, K65R, L74I, K219E, M184V, K101E, V106M, Y181C or G190A. Resistance mutations were identified using the Stanford Calibrated Population Resistance Tool.</p